-
Loading metrics
The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
- Christy M. Hebner,
- Bin Han,
- Katherine M. Brendza,
- Michelle Nash,
- Maisoun Sulfab,
- Yang Tian,
- Magdeleine Hung,
- Wanchi Fung,
- Randall W. Vivian,
- James Trenkle
x
- Published: June 13, 2012
- https://doi.org/10.1371/journal.pone.0039163